Adult women's attitudes toward the HPV vaccine

Journal of Women's Health

Volumn 19, Issue 7, 2010, Pages 1305-1311

  Short, Mary B ^a,b   Rosenthal, Susan L ^c   Sturm, Lynne ^d   Black, Lora ^a,b   Loza, Melissa ^a   Breitkopf, Daniel ^e   Zimet, Gregory D ^d  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b UNIVERSITY OF HOUSTON CLEAR LAKE   (United States)

^c Columbia University School of Medicine ^*  (United States)

^d INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

ADULT; ARTICLE; ATTITUDE TO HEALTH; CLINICAL ARTICLE; DEMOGRAPHY; DRUG COST; FAMILY HISTORY; FEMALE; GROUPS BY AGE; GYNECOLOGY; HUMAN; INTERVIEW; PAPANICOLAOU TEST; PRIORITY JOURNAL; QUESTIONNAIRE; SEXUAL BEHAVIOR; VACCINATION; WOMEN'S HEALTH;

ADULT; ATTITUDE TO HEALTH; FEMALE; HUMANS; INTERVIEWS AS TOPIC; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; QUESTIONNAIRES; RISK FACTORS;

EID: 77954294808     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.2009.1471     Document Type: Article

References (36)

1. Datta SD, Koutsky LA, Ratelle S, et al. Human papilloma-virus infection and cervical cytology in women screened for cervical cancer in the United States, 2003-2005. Ann Intern Med 2008;148:493-500.
2. Giuliano AR, Lazcano E, Villa LL, et al. Circumcision and sexual behavior: Factors independently associated with human papillomavirus detection among men in the HIM study. Int J Cancer 2008. Epub.
3. Fakhry C, Gillison ML. Clinical implications of human papillomavirus in head and neck cancers. Clin Oncol. 2006;24:2606-2611.
4. Dinh T, Sternberg M, Dunne EG, Markowitz LE. Genital warts among 18-to 59-year-olds in the United States, National Health and Nutrition Examination Survery, 1999-2004. Sex Transm Dis 2008;35:357-360.
5. Derkay CS, Wiatrak B. Recurrent respiratory papillomatosis: A review. Laryngoscope 2008;118:1236-1247.
6. Joura EA, Leodolter S, Hernandez-Avila M, et al. Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: A combined analysis of three randomised clinical trials. Lancet 2007;369:1693-1702.
7. Paavonen J, Jenkins D, Bosch FX, et al. Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: An interim analysis of a phase III double-blind, randomized controlled trial. Lancet 2007;369: 2161-2170.
8. Schiller JT, Castellsague X, Villa LL, Hildesheim A. An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial results. Vaccine 2008;26S: K53-K61.
9. Schwarz TF, Spaczynski M, Schneider A, et al. Im-munogenicity and tolerability of HPV-16/18 AS04-adjuvanted prophylactic cervical cancer vaccine in women aged 15-55 years. Vaccine 2009;27:581-587.
10. Fazekas KI, Brewer NT, Smith JS. HPV acceptability in a rural southern area. J Womens Health 2008;17:539-548.
11. Ferris DG, Waller JL, Owen A, Smith J. HPV vaccine acceptance among midadult women. J Am Board Fam Med 2008;21:31-37.
12. Gerend MA, Lee SC, Shepherd JE. Predictors of human papillomavirus vaccination acceptability among under-served women. Sex Transm Dis 2007;34:468-471.
13. Kahn JA, Rosenthal SL, Hamann T. Attitudes about human papillomavirus in young women. Int J STD AIDS 2003;14: 300-306.
14. Black LL, Zimet GD, Short MB, Sturm L, Rosenthal SL. Literature review of human papillomavirus vaccine acceptability among women over 26 years. Vaccine 2009. Epub.
15. Hopenhayn C, Christian A, Christian WJ, Schoenberg NE. Human papillomavirus vaccine: Knowledge and attitudes in two Appalachian Kentucky counties. Cancer Causes Control 2007;18:627-634.
16. Ritchie J, Spencer L. Qualitative data analysis for applied policy research. In: Bryman A, Burgess RG, eds. Analyzing qualitative data. New York: Routledge, 1994:173-194.
17. Cuschieri KS, Horne AW, Szarewski A, Cubie HA. Public awareness of human papillomavirus. J Med Screen 2006; 13:201-207.
18. Friedman AL, Shepeard H. Exploring the knowledge, attitudes, beliefs, and communication preferences of the general public regarding HPV: Findings from CDC focus group research and implications for practice. Health Educ Behav 2007;34:471-485.
19. Walsh CD, Gera A, Shah M, Sharma A, Powell JE, Wilson S. Public knowledge and attitudes towards human papillo-mavirus (HPV) vaccination. BMC Public Health 2008;8: 368-372.
20. Donders, GGG, Gabrovska M, Bellen G, et al. Knowledge of cervix cancer, human papilloma virus (HPV) and HPV vaccination at the moment of introduction of the vaccine in women in Belgium. Arch Gynecol Obstet 2008;4:291-298.
21. Pitts MK, Dyson SJ, Rosenthal DA, Garland SM. Knowledge and awareness of human papillomavirus (HPV): Attitudes towards HPV vaccination among a representative sample of women in Victoria, Australia. Sex Health 2007;4:177-180.
22. Anhang R, Stryker JE, Wright TC, Goldie SJ. News media coverage of human papillomavirus. Cancer 2004;100: 308-314.
23. Rosenthal SL, Rupp R, Zimet GD, et al. Uptake of HPV vaccine: Demographics, sexual history and values, parenting style, and vaccine attitudes. J Adolesc Health 2008;43: 239-245.
24. Toffolon-Weiss M, Hagan K, Leston J, Peterson L, Provost E, Hennessy T. Alaska Native parental attitudes on cervical cancer, HPV and the HPV vaccine. Int J Circumpolar Health 2008; 67:363-373.
25. Johnson DR, Nichol KL, Lipczynski K. Barriers to adult immunization. Am J Med 2008;121:S28-S35.
26. Kwan TTC, Chan KKL, Yip AMW, et al. Barriers and facilitators to human papillomavirus vaccination among Chinese adolescent girls in Hong Kong: A qualitative-quantitative study. Sex Transm Infect 2008;84:227-232.
27. Scarinci IC, Garces-Palacio IC, Partridge EE. An examination of acceptability of HPV vaccination among African American women and Latina immigrants. J Womens Health 2007;16:1224-1233.
28. Kim JJ, Brisson M, Edmunds WJ, Goldie SJ. Modeling cervical cancer prevention in developed countries. Vaccine 2008;26:K76-K86.
29. Slomovitz BM, Sun CC, Frumovitz M, et al. Are women ready for the HPV vaccine? Gynecol Oncol 2006;103:151-154.
30. Kersten G, Hirschberg H. Needle-free vaccine delivery. Expert Opin Drug Deliv 2007;4:459-474.
31. Neubrand TPL, Breitkopf CR, Rupp R, Breitkopf D, Rosenthal SL. Factors associated with completion of the human papillomavirus vaccine series. Clin Pediatr 2009;48: 966-969.
32. Zimet GD, Mays RM, Sturm LA, Ravert AA, Perkins SM, Juliar BE. Parental attitudes about sexually transmitted vaccination for their adolescent children. Arch Pediatr Adolesc Med 2005;159:132-137.
33. Middleman AB, Rosenthal SL, Rickert VI, et al. Adolescent immunization: A position paper of the Society for Adolescent Medicine. J Adolesc Health 2006;38:321-327.
34. Pinkerton SD. Sexual risk compensation and HIV/STD transmission: Empirical evidence and theoretical considerations. Risk Analysis 2001;21:727-736.
35. Center for Disease Control and Prevention and National Immunization Program. Record of the meeting of the Advisory Committee on Immunization Practices. Available at www.cdc.gov/vaccines/recs/acip/downloads/min-feb06. pdf Accessed June 3, 2009.
36. Marlow LA, Forster AS, Wardle J, Waller J. Mothers' and adolescents' beliefs about risk compensation following HPV vaccination. J Adolesc Health 2009;44:446-451.